Public Company News
Pop Culture Announces Improvement in Overall Operations During the Fiscal Year Ended June 30, 2024
XIAMEN, China, Nov. 19, 2024 /PRNewswire/ -- In the fiscal year ended June 30, 2024, POP CULTURE GROUP CO., LTD. ("Pop Culture," or the "Company," Nasdaq: CPOP) continued to focus on its three business lines ——brand promotion, event hosting, event planning and execution, actively made efforts in ...
2024-11-19 21:00
2269
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Highlights: * Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS) * Neurizon's lead drug NUZ-001 and its major active metabolite significantly and dose-dependently prevented the aggregation of TAR DNA-binding protein 43 (TDP-43) by ~...
2024-11-19 20:30
3687
Baijiayun Contributes to the "Urban and Rural School Community" Project, Empowering an Infinite Future for Smart Education
BEIJING, Nov. 19, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, recently made contributions to the " Urban and Rural School Community " project. On November 11th, the training work for the "Urban and Rural School Com...
2024-11-19 19:28
2416
Mega Matrix Announced that the English Version of Short Drama "When My Son Choose His Wife" Premiered on FlexTV on November 19
SINGAPORE, Nov. 19, 2024 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), today announced that the English version of the emotional short dramaWhen My Son Choose His Wife is now available on FlexTV, its world-leading short drama streaming platform. Set against the ...
2024-11-19 18:30
2831
Vipshop Reports Unaudited Third Quarter 2024 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on November 19, 2024 GUANGZHOU, China, Nov. 19, 2024 /PRNewswire/ -- Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands inChina ("Vipshop" or the "Company"), today announced its unaudited financial results...
2024-11-19 18:00
2697
Noah to Host Corporate Open Day on December 6, 2024, in Hong Kong
SHANGHAI, Nov. 19, 2024 /PRNewswire/ -- Noah Holdings Limited (the "Company" or "Noah") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset allocation primarily for Mandarin-speaking high-net...
2024-11-19 17:35
2689
Weibo Announces Third Quarter 2024 Unaudited Financial Results
BEIJING, Nov. 19, 2024 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB and HKEX: 9898), a leading social media inChina, today announced its unaudited financial results for the third quarter endedSeptember 30, 2024. "We had a solid quarter," said Gaofei Wang, CEO of Weibo...
2024-11-19 17:15
2513
Gaotu Techedu to Report Third Quarter 2024 Financial Results on December 4, 2024
BEIJING, Nov. 19, 2024 /PRNewswire/ -- Gaotu Techedu Inc. ("Gaotu" or the "Company") (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider inChina, today announced that it will report its financial results for the third quarter endedSeptember 30, 202...
2024-11-19 16:00
2204
Hyundai Mobis Outlines Value-Up Strategy at CEO Investor Day
Aiming for 8% Annual Revenue Growth and Operating Margin of 5~6% by 2027! - Held the 2024 CEO Investor Day on the 19th … Targeting 40% of global OE sales in auto component manufacturing by 2033 - Focusing on securing leading technological competitiveness and improving business structure centered...
2024-11-19 14:15
2256
Zepp Health Corporation Reports Third Quarter 2024 Unaudited Financial Results
MILPITAS, Calif., Nov. 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues ofUS$42.5 million; a basic and diluted net loss per share ofUS$0.05; and a basic and diluted net loss per ADS ofUS$0.82 for the third quarter ended September 30, ...
2024-11-19 09:00
2622
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
* SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using analpha-particle emitting radioisotope, actinium-225, for potential cancer treatments * The two sides aim to submit an Investigatio...
2024-11-19 08:00
2903
FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results
-Third Quarter Total Transaction Volume reached RMB52.2 billion, up 1.8% year-over-year- -Third Quarter International Transaction Volume reached RMB2.7 billion, up 22.7% year-over-year- -Third Quarter International Revenues increased to RMB635.5 million, up 8.7% year-over-year, contributing 19.4%...
2024-11-19 06:00
3078
Trip.com Group Limited Reports Unaudited Third Quarter of 2024 Financial Results
SINGAPORE, Nov. 18, 2024 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and corporate travel management, today announced its u...
2024-11-19 06:00
3183
Tuya Reports Third Quarter 2024 Unaudited Financial Results
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Tuya Inc. ("Tuya" or the " Company") (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service provider, today announced its unaudited financial results for the third quarter endedSeptember 30, 2024. Third Quarter 2024 Financial Highlight...
2024-11-19 05:05
2769
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024
* 78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and safety results; Results support the therapeutic equivalence of CT-P41 and reference denosumab in...
2024-11-19 02:15
2467
Shengfeng Development Limited Announces Joint Venture with Fujian Fulai Aviation to Expand Low-Altitude Logistics Services
FUZHOU, China, Nov. 18, 2024 /PRNewswire/ -- Shengfeng Development Limited ("Shengfeng" or the "Company") (NASDAQ: SFWL), a contract logistics company in China providing customers with integrated logistics solutions, announced today that onNovember 5, 2024, Shengfeng Logistics Group, a variable in...
2024-11-18 22:15
2566
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, ...
2024-11-18 22:00
2951
Caravelle International Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
HONG KONG, Nov. 18, 2024 /PRNewswire/ -- Caravelle International Group (NASDAQ: HTCO), a global ocean technology company, today announced that it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq"), informing the Company that it has rega...
2024-11-18 22:00
2553
Massimo Announces Expansion of Successful Partnership with Rural King for 2025
Expanded Massimo Lineup of UTVs, ATVs, Go-Karts, Golf Carts and Mini Bikes to be Available Online at Rural King's Website and in Select Stores Throughout 2025 GARLAND, Texas, Nov. 18, 2024 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo"), a manufacturer and distributor of powersports vehi...
2024-11-18 22:00
2363
Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
* Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9% shares of common stock of Aclaris Therapeutics; additional regulatory and sales milestone payments exceed$900M with tiered single digit sal...
2024-11-18 21:50
5206
Week's Top Stories
Most Reposted
InfoComm Asia 2026 - Asia's Super Connector for Professional AV - Takes Place Next Week in Bangkok
[Picked up by 297 media titles]
2026-07-07 09:00
A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 292 media titles]
2026-07-10 13:30
PropertyGuru Group's 2025 Sustainability Report Reinforces its Commitment to More Resilient and Inclusive Urban Futures Across Southeast Asia
[Picked up by 291 media titles]
2026-07-08 12:09
NCS launches enterprise AI platforms and products; deepens partnerships to accelerate AI-driven business transformation
[Picked up by 286 media titles]
2026-07-09 08:00Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
[Picked up by 285 media titles]
2026-07-07 06:00
Most Read
Founder Olive Tai Appointed Chairman of the Board of Synagistics; John Wu Appointed Chief Executive Officer as Company Enters Next Stage of AI and Digital Commerce Growth
2026-07-06 20:23
8325
Bank of America brings together Sir David Beckham and a new U2 song for Street of Dreams, a short film highlighting how support, belief and sport can change a young person's future.
2026-07-08 21:01
6196
NYSE Content Update: Trump Accounts Launch with $1,000 Eligibility
2026-07-06 20:55
6068